We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

HTG Molecular Diagnostics and PROOF Centre Partner to Commercialize COPD Prognostic Test

News   Nov 27, 2012

 
HTG Molecular Diagnostics and PROOF Centre Partner to Commercialize COPD Prognostic Test
 
 
 

RELATED ARTICLES

New Biomarkers Detect 70% of Pancreatic Cancer, a Vast Improvement

News

A new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before it reaches more advanced and difficult-to treat stages.

READ MORE

World Trade Center Responders at Increased Risk of Head and Neck Cancers

News

The study, which is the first to report on head and neck cancers in World Trade Center first responders, found a 40 percent increase in diagnosis of these diseases between 2009 and 2012.

READ MORE

Small Moth’s Big Genome Could Be Key to Ending Deforestation

News

In research that could lead to better bioinsecticides to protect forests and orchards, scientists have sequenced the genomes of the European gypsy moth (GM) and its even more destructive cousin, the Asian gypsy moth (AGM).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE